about
Hybrid PET/MR Imaging and Brain ConnectivityInfluence of left ventricular cavity size on clinical presentation in hypertrophic cardiomyopathy.Partial splenic embolization in patients with idiopathic portal hypertension.A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniquesScintigraphic detection of multidrug resistance in cancer.Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Correlative imaging of cystic lymphangiomas: ultrasound, CT and MRI comparisonComparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patientsCorrelation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma.Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes.Predicting radiation-induced valvular heart damage.Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction.Multiparametric display of spin-echo data from MR studies of brain.Functional characterization of brain tumors: an overview of the potential clinical value.Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancerRadiation therapy in primary orbital lymphoma: a single institution retrospective analysis.PET/CT in cancer research: from preclinical to clinical applications.Fractionated stereotactic radiation therapy for orbital optic nerve sheath meningioma - a single institution experience and a short review of the literature.Unknown primary tumors.Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study.Whole-body FDG PET-MR oncologic imaging: pitfalls in clinical interpretation related to inaccurate MR-based attenuation correction.Evaluation of Quantitative PET/MR Enterography Biomarkers for Discrimination of Inflammatory Strictures from Fibrotic Strictures in Crohn Disease.The Italian affair: The employment of parallel-plate ionization chambers for dose measurements in high dose-per-pulse IORT electron beams.Clinical relevance of thyroid cell models in redox research.Brief report: Mesenchymal stromal cell atrophy in coculture increases aggressiveness of transformed cells.3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement.Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3.An MRI digital brain phantom for validation of segmentation methods.Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans.Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.Prediction of efficacy of octreotide therapy in patients with acromegaly.Long-Term Survival Benefit of Coronary Revascularization in Patients Undergoing Stress Myocardial Perfusion Imaging.Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis.Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
P50
Q26766043-F3D81A7D-FAF5-4583-A855-132C9B96C05BQ33144541-76B8384F-C4F8-479C-8575-2920AA18A611Q33359554-7092BEB2-D31D-4D3D-926C-2C3E6E5E2713Q33738609-51603DE3-64BF-43CA-9F7E-34C2E0DEFA45Q33894885-F51D124B-2B1B-4249-A993-C408C1449C7EQ34065675-E97FF15C-67FE-4FBF-8F1E-33F2E6004B2FQ35500065-BC69DBDD-2848-4B37-9A02-22F7964621DDQ35625141-7AF4C008-3B85-44A7-A66A-87F1BFE73C27Q35677908-D18064B3-0636-4248-B2D7-AA6BEAD8196FQ36510348-A06CACC7-F5DE-41B1-8C32-CBC61B5C8856Q36614170-6284EEEC-70FE-47AC-AA3F-CD0667ED9027Q36661360-40208F30-ECAE-4358-A798-AC75EA921E0FQ36672745-F425E724-5C4A-4649-9018-473446E29091Q36688639-EB14125B-A1B4-4F23-8AAC-1A4E599C59F0Q36705875-4A08060C-5947-44B2-A2F6-B149E37CAC7CQ36835088-7A0E2716-9D9D-4EF6-B4C1-B05FACC7CF2FQ37366354-180D58AA-3B56-4DA6-A1A9-5A55917EF9ECQ37479773-07C97004-54BA-46D4-B125-98DF38D53A97Q37784771-E45E5ACA-922D-427C-9D24-22F7CA746290Q37835609-0EB57F6A-09BC-4A28-B1E9-2E974384F925Q37849370-18FFF24E-1E8F-474C-8048-06FAEAC8BBE4Q38134706-A55ED454-EEE6-4E96-90A1-C84858D5DACFQ38508150-F9F99112-81DF-4AFE-903B-18C347F8A641Q38599238-940612EA-61E2-437C-A06C-4B9DD473F41EQ38781445-44B3FEEC-F2AA-4B8E-9E31-9C8D07DD49BBQ38811899-B4FF1E94-F6FA-4F01-AC9E-C4BF9A5A901EQ39195214-031D4D6D-8673-497E-8781-9FE5777E4372Q39397065-0FCCFEB3-0B79-4E59-A60B-EF4E006F3435Q39685206-1600A632-1023-4AC6-BC52-7818EF40E8A7Q39951339-0659BE8E-6D68-413E-A492-7D9FDAA717C9Q39970791-0607929F-6B1E-4FD7-B555-2B50377A3552Q40177374-66B87BDC-E20E-4C1C-AE1B-968985A90D4CQ40256855-5C384249-E4E0-459F-BF59-D4A4EB5F9595Q40569441-924084AA-03D0-47A1-B387-EC7A5833B2D1Q40608978-10F5CE30-EB37-41BD-B301-FCD47568B4C3Q40936987-9A53492C-1655-4E1F-98FF-7D4DF65A2CBEQ41034860-3A3BFDD9-6F30-4F5F-9C59-8B0B2AFB2F08Q42249787-A87EB06F-51D0-48B3-95F4-24E075B264A8Q42449608-D8A1505F-564C-4A5B-A35E-8230C282FA40Q42554748-DC71D46D-3539-49EF-9A81-9C21192DF366
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marco Salvatore
@ast
Marco Salvatore
@en
Marco Salvatore
@es
Marco Salvatore
@nl
Marco Salvatore
@pt
Marco Salvatore
@sl
type
label
Marco Salvatore
@ast
Marco Salvatore
@en
Marco Salvatore
@es
Marco Salvatore
@nl
Marco Salvatore
@pt
Marco Salvatore
@sl
prefLabel
Marco Salvatore
@ast
Marco Salvatore
@en
Marco Salvatore
@es
Marco Salvatore
@nl
Marco Salvatore
@pt
Marco Salvatore
@sl
P1053
K-8083-2016
P106
P21
P31
P496
0000-0001-9734-7702